ClinicalTrials.gg
RecruitingNCT07700459ACE-CHDUpdated Sep 30, 2026

Exercise Prehabilitation in Congenital Heart Disease

An interventional study of Exercise prehabilitation in Congenital Heart Disease and Cardiac Surgery, sponsored by Liverpool Heart and Chest Hospital NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Liverpool Heart and Chest Hospital NHS Foundation Trust · Not applicable, Interventional, and Prevention

How we know · 2 judgments

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Sep 30, 2026Now RecruitingFirst site in United Kingdom+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Heart Defects, Congenital with a site in United Kingdom — 10 open to participants now, 11 under way, none of them phase 3. Heart Defects, Congenital · United Kingdom.

Planned enrollment
11th of 17
32 · median 50
Started
2026
with 3 others
No phase
9 of 32
4 open now
Primary completion
2029-06
later than 8 of 10 live
Registered
31st of 32
by date

Among the 32 studies in Heart Defects, Congenital with a site in United Kingdom, this one is the 11th largest by planned enrollment of the 17 interventional ones that give a count, is one of 4 that started in 2026, is one of 9 with no phase, reaches primary completion later than 8 of the 10 other live ones, and was the 31st registered.

Heart Defects, Congenital

992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.

Browse Heart Defects, Congenital studies →

Open to participants now

10 of the 32 studies in Heart Defects, Congenital with a site in United Kingdom are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Heart Defects, Congenital with a site in United Kingdom, or all of them as a file.
02

Study summary

Around 8-12 in every 1000 babies are born with an abnormal heart, known as a congenital heart defect (CHD).

Thanks to major advances in medical and surgical care, most babies born with CHD now live into adulthood.

As people with CHD get older, many need repeated heart operations. It is known from other areas of medicine that "prehabilitation" - a short, structured exercise programme completed before surgery - can improve fitness and help patients cope better with major operations. However, this approach has never been tested in adults with CHD. The investigators are running a randomised controlled trial to find out whether a prehabilitation programme can improve physical fitness before heart surgery in adults with CHD.

Participants will be randomly assigned to usual care or a prehabilitation group. Those in the prehabilitation group will follow a tailored, supervised exercise plan for several weeks before surgery.

All patients undergoing cardiac surgery routinely complete a cardiopulmonary exercise test (CPET) as part of their standard pre-operative assessment. CPET is a well-established test that shows how the heart and lungs respond to increasing levels of exercise. During the test, participants exercise on a bike while their breathing, heart rate, and overall physiological response are continuously monitored.

The results of each participant's routine CPET will be used to guide the individualised exercise programme in the intervention group.

Exercise levels prescribed in the study will not exceed the intensity already safely achieved during the routine CPET, ensuring that activity remains within clinically assessed limits.

Participants in the trial will complete an additional second CPET following the trial period.

The key question is whether a tailored exercise programme can improve fitness in adults with CHD before heart surgery, and whether this approach is feasible, acceptable and practical to deliver, including successful recruitment and measurable physiological improvements.

03

Conditions studied

  • Congenital Heart Disease
  • Cardiac Surgery

Keywords

  • Congenital heart disease
  • Prehabilitation
  • Cardiac surgery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults with congenital heart disease requiring cardiac surgery via sternotomy or thoracotomy.
  • Capacity to provide .
  • Ability and willingness to engage in exercise-based interventions.
  • Peak VO2 \<30ml/kg/min at preoperative exercise assessment.
  • Participant reached peak VO2 in preoperative exercise assessment (RER >1.0).
  • Ability to communicate in English.

Exclusion criteria

Exclusion Criteria:

  • Surgery is scheduled for a date that precludes participation in the programme - surgical date is \<9 weeks away.
  • Pregnancy of \<6 months postpartum.
  • History of pneumothorax within the last 3 months.
  • Resting oxygen saturations \<94%.
  • Uncorrected right-to-left shunt with exercise.
  • Fontan physiology.
  • Pulmonary hypertension.
  • Critical valvular obstruction.
  • Sustained ventricular arrhythmia.
  • Severe aortic dilatation (>45mm in Marfan syndrome or hereditary aortopathy, >50mm in bicuspid or tricuspid aortic valves).

The oldest person operated upon by the ACHD service was 78 years old. Upper age is not an exclusion criteria.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Prehabilitation Arm

    Participants will undertake a bespoke 6-week prehabilitation programme designed with an exercise physiologist. The programme is individualised based on CPET results, baseline activity, and patient capability. It includes cardiovascular, respiratory, and resistance training. Aerobic exercise is prescribed using a progressive Rating of Perceived Exertion (RPE) approach, targeting 150-300 minutes/week of moderate-intensity activity in line with ESC guidance, with warm-up and cool-down. Respiratory training is delivered using an inspiratory muscle trainer. Resistance training targets major muscle groups (15-30 repetitions) using bands, with additional handgrip exercises. Equipment is provided. Participants also receive dietary and lifestyle advice with ongoing clinical support.

    Other: Exercise prehabilitation

  • No intervention
    Control Arm

    Standard preoperative management, which includes routine surgical clinic assessments, medical clinic appointments, preoperative nursing reviews and access to the ACHD nurse helpline as normal.

Interventions

  • OtherExercise prehabilitation

    Participants undertake a bespoke 6-week prehabilitation programme designed with an exercise physiologist, individualised to CPET results, baseline activity, and patient capability. It includes aerobic (progressive RPE-based, targeting 150-300 min/week moderate intensity with warm-up/cool-down), respiratory (inspiratory muscle training), and resistance training (major muscle groups, 15-30 repetitions, plus handgrip exercises). Equipment is provided. Participants also receive dietary and lifestyle advice with ongoing clinical support. Anxiety is addressed by the research team, with referral to psychology if required. Adherence is supported with at least fortnightly contact (phone/email/text). All participants undergo repeat CPET at 7-9 weeks. Participants are encouraged to continue exercises until surgery where feasible.

06

What researchers measure

Primary outcomes

  1. Within-participant change in peak VO2 as measured on cardiopulmonary exercise test (CPET) at baseline and follow-up.

    The primary outcome will be the within-participant change in peak VO2 as measured on cardiopulmonary exercise test (CPET) at baseline and at follow-up.

    Time frame: Baseline and follow-up CPETs (up to 9 weeks apart).

Secondary outcomes

  1. Individual change in forced vital capacity (litres) at baseline and follow-up.

    Best of three acceptable attempts after usual inhaled medications (if taken) at baseline and follow-up. This is a routine measurement on a CPET at LHCH.

    Time frame: Baseline and follow-up CPETs (up to 9 weeks apart)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • NHS Liverpool Clinical Commissioning Group. One Liverpool Strategy 2019-2024. In: NHS England, ed. Online; 2019.
  • Department of Health and Social Care. Fit for the future: 10 Year Health Plan for England. In: Care DoHaS, ed. Online; 2025.
  • NHS England. NHS Long Term Plan. In: England N, ed; 2019.
  • Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13. PubMed 16367493 ↗
  • Pelliccia A, Sharma S, Gati S, Back M, Borjesson M, Caselli S, Collet JP, Corrado D, Drezner JA, Halle M, Hansen D, Heidbuchel H, Myers J, Niebauer J, Papadakis M, Piepoli MF, Prescott E, Roos-Hesselink JW, Graham Stuart A, Taylor RS, Thompson PD, Tiberi M, Vanhees L, Wilhelm M; ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021 Jan 1;42(1):17-96. doi: 10.1093/eurheartj/ehaa605. No abstract available. PubMed 32860412 ↗
  • Ferrero P, Piazza I, Poggioli G, Chessa M, Lorenzelli F. Long-term effects of physical training on cardiopulmonary exercise parameters in young patients with congenital heart diseases. Cardiol Young. 2024 Apr;34(4):831-837. doi: 10.1017/S1047951123003621. Epub 2023 Oct 23. PubMed 37869879 ↗
  • Bargnes V 3rd, Davidson S, Talbot L, Jin Z, Poppers J, Bergese SD. Start Strong, Finish Strong: A Review of Prehabilitation in Cardiac Surgery. Life (Basel). 2024 Jun 29;14(7):832. doi: 10.3390/life14070832. PubMed 39063586 ↗
  • McIsaac DI, Kidd G, Gillis C, Branje K, Al-Bayati M, Baxi A, Grudzinski AL, Boland L, Veroniki AA, Wolfe D, Hutton B. Relative efficacy of prehabilitation interventions and their components: systematic review with network and component network meta-analyses of randomised controlled trials. BMJ. 2025 Jan 22;388:e081164. doi: 10.1136/bmj-2024-081164. PubMed 39843215 ↗
  • Assouline B, Cools E, Schorer R, Kayser B, Elia N, Licker M. Preoperative Exercise Training to Prevent Postoperative Pulmonary Complications in Adults Undergoing Major Surgery. A Systematic Review and Meta-analysis with Trial Sequential Analysis. Ann Am Thorac Soc. 2021 Apr;18(4):678-688. doi: 10.1513/AnnalsATS.202002-183OC. PubMed 33030962 ↗
  • Shen F, Kim HJ, Lee NK, Chun HJ, Chang BS, Lee CK, Yeom JS. The influence of hand grip strength on surgical outcomes after surgery for degenerative lumbar spinal stenosis: a preliminary result. Spine J. 2018 Nov;18(11):2018-2024. doi: 10.1016/j.spinee.2018.04.009. Epub 2018 Apr 18. PubMed 29679727 ↗
  • Hunt DR, Rowlands BJ, Johnston D. Hand grip strength--a simple prognostic indicator in surgical patients. JPEN J Parenter Enteral Nutr. 1985 Nov-Dec;9(6):701-4. doi: 10.1177/0148607185009006701. PubMed 4068194 ↗
  • Park HJ, Kim SM, Kim HR, Ji W, Choi CM. The value of preoperative spirometry testing for predicting postoperative risk in upper abdominal and thoracic surgery assessed using big-data analysis. J Thorac Dis. 2020 Aug;12(8):4157-4167. doi: 10.21037/jtd-19-2687. PubMed 32944327 ↗
  • Amirkhosravi F, Allenson KC, Moore LW, Kolman JM, Foster M, Hsu E, Sasangohar F, Dhala A. Multimodal prehabilitation and postoperative outcomes in upper abdominal surgery: systematic review and meta-analysis. Sci Rep. 2024 Jul 11;14(1):16012. doi: 10.1038/s41598-024-66633-6. PubMed 38992072 ↗
  • Roxburgh BH, Cotter JD, Campbell HA, Reymann U, Wilson LC, Gwynne-Jones D, van Rij AM, Thomas KN. Physiological relationship between cardiorespiratory fitness and fitness for surgery: a narrative review. Br J Anaesth. 2023 Feb;130(2):122-132. doi: 10.1016/j.bja.2022.10.039. Epub 2022 Dec 16. PubMed 36529576 ↗
  • Rose GA, Davies RG, Appadurai IR, Williams IM, Bashir M, Berg RMG, Poole DC, Bailey DM. 'Fit for surgery': the relationship between cardiorespiratory fitness and postoperative outcomes. Exp Physiol. 2022 Aug;107(8):787-799. doi: 10.1113/EP090156. Epub 2022 Jun 5. PubMed 35579479 ↗
  • Steffens D, Ismail H, Denehy L, Beckenkamp PR, Solomon M, Koh C, Bartyn J, Pillinger N. Preoperative Cardiopulmonary Exercise Test Associated with Postoperative Outcomes in Patients Undergoing Cancer Surgery: A Systematic Review and Meta-Analyses. Ann Surg Oncol. 2021 Nov;28(12):7120-7146. doi: 10.1245/s10434-021-10251-3. Epub 2021 Jun 8. PubMed 34101066 ↗
  • Sterrett LE, Ebenroth ES, Query C, Ho J, Montgomery GS, Hurwitz RA, Baye F, Schamberger MS. Why exercise capacity does not improve after pulmonary valve replacement. Pediatr Cardiol. 2014 Dec;35(8):1395-402. doi: 10.1007/s00246-014-0942-2. Epub 2014 Jul 3. PubMed 24990282 ↗
  • Le VD, Jensen GV, Kjoller-Hansen L. Observed change in peak oxygen consumption after aortic valve replacement and its predictors. Open Heart. 2016 May 26;3(1):e000309. doi: 10.1136/openhrt-2015-000309. eCollection 2016. PubMed 27252876 ↗
  • Lopez KN, Baker-Smith C, Flores G, Gurvitz M, Karamlou T, Nunez Gallegos F, Pasquali S, Patel A, Peterson JK, Salemi JL, Yancy C, Peyvandi S; American Heart Association Congenital Cardiac Defects Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Epidemiology and Prevention; and Council on Lifestyle and Cardiometabolic Health. Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2022 Apr 19;11(8):e025358. doi: 10.1161/JAHA.122.025358. Epub 2022 Apr 7. PubMed 35389228 ↗
  • Niwa K. Metabolic syndrome and coronary artery disease in adults with congenital heart disease. Cardiovasc Diagn Ther. 2021 Apr;11(2):563-576. doi: 10.21037/cdt-20-781. PubMed 33968634 ↗
  • Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012 Jan;70(1):3-21. doi: 10.1111/j.1753-4887.2011.00456.x. PubMed 22221213 ↗
  • Bar-Mor G, Bar-Tal Y, Krulik T, Zeevi B. Self-efficacy and physical activity in adolescents with trivial, mild, or moderate congenital cardiac malformations. Cardiol Young. 2000 Nov;10(6):561-6. doi: 10.1017/s1047951100008829. PubMed 11117387 ↗
  • Bar-Mor G, Zeevi B, Yaaron M, Falk B. Use of the heart rate monitor to modulate physical activity in adolescents with congenital aortic stenosis: an innovative approach. J Pediatr Nurs. 1999 Aug;14(4):273-7. doi: 10.1016/S0882-5963(99)80026-8. PubMed 10467807 ↗
  • Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005 Aug 9;112(6):828-35. doi: 10.1161/CIRCULATIONAHA.104.529800. Epub 2005 Aug 1. PubMed 16061735 ↗
  • Silvapulle E, Darvall J. Objective methods for preoperative assessment of functional capacity. BJA Educ. 2022 Aug;22(8):312-320. doi: 10.1016/j.bjae.2022.03.003. Epub 2022 May 25. No abstract available. PubMed 36097575 ↗
  • Constantine A, Costola G, Bianchi P, Chessa M, Giamberti A, Kempny A, Rafiq I, Babu-Narayan SV, Gatzoulis MA, Hoschtitzky A, Shore D, Aw TC, Ranucci M, Dimopoulos K. Enhanced Assessment of Perioperative Mortality Risk in Adults With Congenital Heart Disease. J Am Coll Cardiol. 2021 Jul 20;78(3):234-242. doi: 10.1016/j.jacc.2021.04.096. PubMed 34266577 ↗
  • Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos-Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K; ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645. doi: 10.1093/eurheartj/ehaa554. No abstract available. PubMed 32860028 ↗
  • Marmelo F, Rocha V, Moreira-Goncalves D. The impact of prehabilitation on post-surgical complications in patients undergoing non-urgent cardiovascular surgical intervention: Systematic review and meta-analysis. Eur J Prev Cardiol. 2018 Mar;25(4):404-417. doi: 10.1177/2047487317752373. Epub 2018 Jan 17. PubMed 29338307 ↗
  • McCann M, Stamp N, Ngui A, Litton E. Cardiac Prehabilitation. J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2255-2265. doi: 10.1053/j.jvca.2019.01.023. Epub 2019 Jan 12. PubMed 30765210 ↗

Individual participant data

Plan to share: No — Pooled data will be published.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Jun 2029, 33 months after the start.

Of 208 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 33 months is close to that.

Counting every sponsor, half of 226 studies reached it within 34 months; a quarter within 17 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2026
First posted
Jul 14, 2026
StartActual
Aug 28, 2026
Primary completionEst.
Jun 1, 2029
CompletionEst.
Jun 1, 2029
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Sep 30, 2026
Sites
1 site added — first site in United Kingdom
Show site
  • Liverpool Heart and Chest Hospital NHS Foundation Trust · Liverpool, United Kingdom
Sep 30, 2026
Start date
Aug 10, 2026→Aug 28, 2026 (actual)
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United Kingdom
    Show site
    • Liverpool Heart and Chest Hospital NHS Foundation Trust · Liverpool, United Kingdom
    Start date Aug 10, 2026→Aug 28, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07700459
Lead sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust
Collaborators
Liverpool John Moores University
Responsible party
Sponsor
First posted
Jul 14, 2026
Start date
Aug 28, 2026
Primary completion
Jun 1, 2029 (estimated)
Completion
Jun 1, 2029 (estimated)
Last update
Sep 30, 2026

Study contacts

Elen H Hughes, MBBCh
Contact
elen.hughes@lhch.nhs.uk
+44 01516001616
Julia D Jones, MD
Contact
julia.jones3@lhch.nhs.uk
+44 01516001616
Julia D Jones, MD
principal investigator · Liverpool Heart and Chest Hospital NHS Foundation Trust

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion